Overview
At DNA Labs India, we offer eukaryotic mRNA sequencing and reference-based analysis for individuals seeking to understand the genetic basis of their symptoms. This cutting-edge technology is designed to provide a comprehensive view of a patient's genetic makeup and can be used to diagnose a wide range of conditions. The process involves sequencing the mRNA of a eukaryotic organism and comparing the results to a reference genome, allowing us to identify genetic variations that may be responsible for a patient's symptoms or condition. The steps include RNA extraction, library preparation, high-throughput sequencing, alignment to a reference genome, and detailed analysis of genetic variations. This test is particularly useful when DNA sequencing has not provided a definitive diagnosis, as it can reveal abnormalities in gene expression, splicing, and transcript structure. With a cost of INR 24000, the test includes all necessary procedures and a personalized report. DNA Labs India is committed to providing accurate and timely results, with free home sample collection available across major cities in India.
To be completed — reclassified from Tests on 2026-11-13.
The purpose of eukaryotic mRNA sequencing and reference-based analysis is to identify genetic variations that affect gene expression and splicing, which may be the underlying cause of a patient's symptoms. Unlike DNA sequencing, which looks at the genetic code, mRNA sequencing examines the actual transcripts produced, providing a functional readout of gene activity. This can help diagnose conditions where DNA variants are not clearly pathogenic, or where the disease mechanism involves abnormal RNA processing. The test is also valuable for detecting fusion genes, alternative splicing events, and allele-specific expression, which are important in cancer and genetic disorders.
Sample requirements
What to send us
Deliverables & turnaround
What you receive
Turnaround: Reports are typically available within 8 weeks from sample receipt.
Pricing
Transparent pricing
| Option | Turnaround | Price (INR) | Unit |
|---|---|---|---|
| Standard | Reports are typically available within 8... | ₹24,000 | per sample |
Limitations & precautions
What this service cannot do
Questions customers ask
Frequently asked questions
What is eukaryotic mRNA sequencing?
It is a technique that sequences the messenger RNA of a eukaryotic organism to analyze gene expression and identify variations that may cause disease.
How is this test different from DNA sequencing?
DNA sequencing looks at the genetic code, while mRNA sequencing examines the actual transcripts, providing information about gene expression and splicing.
What conditions can this test diagnose?
It can help diagnose developmental disorders, neurological conditions, cancer, cardiovascular diseases, infectious diseases, and autoimmune disorders.
What sample is required?
The test requires an extracted DNA sample, typically obtained from a blood draw.
Is fasting required before the test?
No, fasting is not required for this test.
How long does it take to get results?
Results are typically available within 8 weeks after the sample is received.
What is the cost of the test?
The cost is INR 24000, which includes all procedures and a detailed report.
Is home sample collection available?
Yes, we offer free home sample collection for online bookings across major cities in India.
Will my insurance cover this test?
Insurance coverage varies; please check with your provider. We can provide a detailed invoice for reimbursement.
Are there any risks associated with the test?
The test involves a simple blood draw, which carries minimal risks such as bruising or infection.
Can this test detect all genetic disorders?
No, it is not comprehensive for all genetic disorders. It is most useful for conditions involving gene expression or splicing abnormalities.
How should I prepare for the test?
No special preparation is needed. Inform your doctor about any medications you are taking.
Continue here
Related services
Enquiry
Request a quote or ask a question
Editorial accountability